Skip to main content
Premium Trial:

Request an Annual Quote

Axygen Scientific Launches New Business Unit to Focus on Genomics, Proteomics Technology

NEW YORK, Feb. 4 (GenomeWeb News) - Axygen Scientific has created a new subdivision called Axygen Bioscience that focuses on genomics, proteomics, and protein crystallography.


The company decided to create the new division in order to expand into the area of proteomics, which executives identified as one of the key areas for pharmaceutical companies, Arezou Arazani, director of new product and business development at Axygen Bioscience, told GenomeWeb News.


"They brought me into the company and said they wanted to get into new technology," said Arazani. "I said the future is in proteomics. Most pharma companies have genetic information from humans and other species, but they need the protein for more information. The new technology covers all the area from DNA to protein crystallography."


Based in Union City, Calif., Axygen Bioscience has over 400 employees, 100 of whom were new hires and 50 of whom are scientists, said Arazani.


Products produced by the new division include nucleic acid and peptide purification kits, markers, crystallography plates, sealers, reagents, software, databases, and high-throughput laboratory robotics and automation platforms.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.